1387 studies found for:    Open Studies | "Breast Neoplasms" AND "Breast Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Breast Neoplasms" AND "Breast Diseases" (1387 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions: Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Docosahexaenoic Acid;   Other: Laboratory Biomarker Analysis;   Other: Placebo
2 Not yet recruiting Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.
Conditions: Breast Neoplasms;   Breast Diseases;   Neoplasms;   Neoplasms by Site;   Fulvestrant;   Antineoplastic Agents;   Antineoplastic Agents, Hormonal;   Estrogen Receptor Antagonists;   Hormone Antagonists;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Molecular Mechanisms of Pharmacological Action;   Pharmacologic Actions;   Therapeutic Use
Interventions: Drug: Ribociclib;   Drug: fulvestrant;   Drug: Ribociclib placebo
3 Unknown  Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Conditions: Breast Neoplasms;   Breast Diseases
Intervention: Device: Sysmex's 5-blade lymph node cutter
4 Unknown  ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer
Conditions: Breast Cancer;   Breast Disease;   Neoplasms;   Neoplasms by Site
Intervention: Drug: cyclophosphamide, Adriamycin, Docetaxel, Trastuzumab, Zolendronic acid
5 Recruiting Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
Conditions: Breast Neoplasms;   Neoplasms by Site;   Neoplasm Metastasis;   Breast Diseases;   Skin Diseases
Interventions: Drug: Docetaxel plus Capecitabine;   Drug: Capecitabine
6 Recruiting Johns Hopkins Breast Cancer Program Longitudinal Repository
Conditions: Breast Cancer;   Benign Breast Disease
Intervention: Procedure: Sample collection
7 Recruiting The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction
Conditions: Breast Neoplasms;   Neoplasms by Site;   Neoplasms;   Breast Diseases;   Skin Diseases
Interventions: Drug: Botulinum Toxin-A;   Drug: Saline
8 Recruiting Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
Conditions: Malignant Neoplasm of Breast;   Breast Diseases;   Ductal Breast Carcinoma
Intervention: Radiation: Intraoperative radiation therapy (IORT)
9 Recruiting Oncoplastic Approach to Excisional Breast Biopsies
Conditions: Neoplasm of Female Breast;   Breast Neoplasms Diagnosis;   Breast Diseases;   Deformity of Reconstructed Breast
Interventions: Procedure: Oncoplastic Approach Excisional Breast Biopsy;   Procedure: Conventional Excisional Breast Biopsy;   Other: Tezel Method of Breast Volume Measurement;   Other: Cosmetic Assessment
10 Recruiting Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors
Condition: Breast Cancer
Interventions: Device: Focused Microwave Thermotherapy;   Drug: Chemotherapy (control)
11 Unknown  Women At Risk: The High Risk Breast Cancer Program
Condition: Breast Cancer
Intervention:
12 Recruiting Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
Conditions: Breast Cancer;   Pain, Postoperative;   BRCA1 Mutation;   BRCA2 Mutation;   Breast Diseases;   Neoplasms
Interventions: Drug: Botulinum Toxin Type A;   Drug: Sodium Chloride Solution
13 Unknown  Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women Volunteers
Condition: Breast Neoplasms
Intervention:
14 Recruiting Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer;   Breast Tumors;   Cancer of the Breast;   Neoplasms, Breast;   Tumors, Breast
Interventions: Drug: Eribulin;   Drug: Doxorubicin;   Drug: Cyclophosphamide
15 Recruiting Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Conditions: Stage 0 Breast Carcinoma;   Breast Neoplasms;   Stage I Breast Carcinoma;   Stage II Breast Carcinoma;   Stage III Breast Carcinoma
Interventions: Drug: Metformin;   Drug: Omega-3 fatty acids
16 Recruiting Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasm;   Breast Tumor;   Cancer of the Breast
Intervention: Radiation: Proton Radiotherapy
17 Recruiting GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
Conditions: Estrogen Receptor Negative Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Triple Negative Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: cisplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: dynamic contrast-enhanced MRI, diffusion-weighted MRI & chemical exchange saturation transfer MRI;   Drug: GDC -0941
18 Recruiting Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT)
Conditions: Breast Neoplasms;   Breast Cancer
Interventions: Drug: Taxane;   Drug: Taxotere;   Drug: Abraxane;   Drug: Ixabepilone
19 Recruiting Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Malignant Tumor of the Breast
Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, Capecitabine
20 Not yet recruiting Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
Conditions: Breast Cancer;   Breast Carcinoma;   Breast Tumors;   Malignant Neoplasm of Breast
Interventions: Drug: Paclitaxel;   Drug: Alisertib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years